164 related articles for article (PubMed ID: 25147341)
41. Response gene to complement 32 deficiency causes impaired placental angiogenesis in mice.
Cui XB; Guo X; Chen SY
Cardiovasc Res; 2013 Sep; 99(4):632-9. PubMed ID: 23695833
[TBL] [Abstract][Full Text] [Related]
42. Thrombomodulin promotes placental function by up-regulating placental growth factor via inhibition of high-mobility-group box 1 and hypoxia-inducible factor 1α.
Oda H; Nagamatsu T; Cabral H; Miyazaki T; Iriyama T; Kawana K; Fujii T; Osuga Y
Placenta; 2021 Aug; 111():1-9. PubMed ID: 34126415
[TBL] [Abstract][Full Text] [Related]
43. The discovery of the placental growth factor and its role in angiogenesis: a historical review.
Ribatti D
Angiogenesis; 2008; 11(3):215-21. PubMed ID: 18568405
[TBL] [Abstract][Full Text] [Related]
44. Expression of placenta growth factor mRNA in the rat placenta during mid-late pregnancy.
Choi WS; Cho GJ; Won CK; Koh PO
J Vet Sci; 2005 Sep; 6(3):179-83. PubMed ID: 16131818
[TBL] [Abstract][Full Text] [Related]
45. Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD).
Patel N; Sundaram N; Yang M; Madigan C; Kalra VK; Malik P
J Biol Chem; 2010 May; 285(22):16713-22. PubMed ID: 20351105
[TBL] [Abstract][Full Text] [Related]
46. A critical role of placental growth factor in the induction of inflammation and edema formation.
Oura H; Bertoncini J; Velasco P; Brown LF; Carmeliet P; Detmar M
Blood; 2003 Jan; 101(2):560-7. PubMed ID: 12393422
[TBL] [Abstract][Full Text] [Related]
47. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential.
Cianfarani F; Zambruno G; Brogelli L; Sera F; Lacal PM; Pesce M; Capogrossi MC; Failla CM; Napolitano M; Odorisio T
Am J Pathol; 2006 Oct; 169(4):1167-82. PubMed ID: 17003476
[TBL] [Abstract][Full Text] [Related]
48. The placenta growth factor in skin angiogenesis.
Odorisio T; Cianfarani F; Failla CM; Zambruno G
J Dermatol Sci; 2006 Jan; 41(1):11-9. PubMed ID: 16216466
[TBL] [Abstract][Full Text] [Related]
49. Role of placenta growth factor in cardiovascular health.
Iyer S; Acharya KR
Trends Cardiovasc Med; 2002 Apr; 12(3):128-34. PubMed ID: 12007738
[TBL] [Abstract][Full Text] [Related]
50. VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis.
Fujii T; Yonemitsu Y; Onimaru M; Inoue M; Hasegawa M; Kuwano H; Sueishi K
Atherosclerosis; 2008 Sep; 200(1):51-7. PubMed ID: 18258238
[TBL] [Abstract][Full Text] [Related]
51. Maternal hemoglobin concentration and hematocrit values may affect fetus development by influencing placental angiogenesis.
Stangret A; Wnuk A; Szewczyk G; Pyzlak M; Szukiewicz D
J Matern Fetal Neonatal Med; 2017 Jan; 30(2):199-204. PubMed ID: 27076257
[TBL] [Abstract][Full Text] [Related]
52. Mutation analysis of the growth factor genes PlGF, Flt1, IGF-I, and IGF-IR in intrauterine growth restriction with abnormal placental blood flow.
Muetze S; Kapagerof A; Vlachopoulos L; Eggermann T; Kaufmann P; Zerres K; Rath W; Rudnik-Schoeneborn S
J Matern Fetal Neonatal Med; 2010 Feb; 23(2):142-7. PubMed ID: 19658040
[TBL] [Abstract][Full Text] [Related]
53. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
[TBL] [Abstract][Full Text] [Related]
54. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation.
Yoo SA; Yoon HJ; Kim HS; Chae CB; De Falco S; Cho CS; Kim WU
Arthritis Rheum; 2009 Feb; 60(2):345-54. PubMed ID: 19180491
[TBL] [Abstract][Full Text] [Related]
55. Proteasomal activity in placentas from women with preeclampsia and intrauterine growth restriction: implications for expression of HIF-alpha proteins.
Rajakumar A; Michael HM; Daftary A; Jeyabalan A; Gilmour C; Conrad KP
Placenta; 2008 Mar; 29(3):290-9. PubMed ID: 18222538
[TBL] [Abstract][Full Text] [Related]
56. Placenta growth factor is not required for exercise-induced angiogenesis.
Gigante B; Tarsitano M; Cimini V; De Falco S; Persico MG
Angiogenesis; 2004; 7(3):277-84. PubMed ID: 15609082
[TBL] [Abstract][Full Text] [Related]
57. Maternal serum placental growth factor at 11-13 weeks' gestation and fetal cardiac defects.
Llurba E; Syngelaki A; Sánchez O; Carreras E; Cabero L; Nicolaides KH
Ultrasound Obstet Gynecol; 2013 Aug; 42(2):169-74. PubMed ID: 23151971
[TBL] [Abstract][Full Text] [Related]
58. Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis.
Larcher F; Franco M; Bolontrade M; Rodriguez-Puebla M; Casanova L; Navarro M; Yancopoulos G; Jorcano JL; Conti CJ
Mol Carcinog; 2003 Jun; 37(2):83-90. PubMed ID: 12766907
[TBL] [Abstract][Full Text] [Related]
59. Angiogenic factors in placentas from pregnancies complicated by fetal growth restriction (review).
Gourvas V; Dalpa E; Konstantinidou A; Vrachnis N; Spandidos DA; Sifakis S
Mol Med Rep; 2012 Jul; 6(1):23-7. PubMed ID: 22552373
[TBL] [Abstract][Full Text] [Related]
60. Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts.
Tu HJ; Lin TH; Chiu YC; Tang CH; Yang RS; Fu WM
J Cell Physiol; 2013 May; 228(5):983-90. PubMed ID: 23042533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
